EyePoint (EYPT) Times Interest Earned (2018 - 2024)
EyePoint (EYPT) posted Times Interest Earned of -$2.65 for Q1 2026, down 110.06% sequentially from $26.38 in Q4 2025, and up 81.13% YoY from -$1.47 in Q1 2025.
Powered by 
Analysis
EyePoint (EYPT) Times Interest Earned (2018 - 2024) Analysis & Trends
EyePoint has reported Times Interest Earned for 16 years, with the latest figure at -$2.65 in Q1 2026.
- Quarterly Times Interest Earned rose 81.13% year-over-year to -$2.65 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.57 (up 81.55% YoY) and the FY2025 annual result came in at -$3.33, up 82.94% from the prior year.
- Times Interest Earned fell to -$2.65 in Q1 2026 per EYPT's latest filing, from $26.38 in the prior quarter.
- Over five years, Times Interest Earned peaked at $26.38 in Q4 2025 and troughed at -$64.63 in Q4 2024.
- A 5-year average of -$11.39 and a median of -$1.38 in 2023 frame the typical range for Times Interest Earned.
- The widest YoY moves for Times Interest Earned: up 140.81% in 2025, down 2632.11% in 2025.
- Over 5 years, Times Interest Earned stood at -$63.11 in 2022, then surged by 59.95% to -$25.28 in 2023, then slumped by 155.68% to -$64.63 in 2024, then jumped by 140.81% to $26.38 in 2025, then sank by 110.06% to -$2.65 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$2.65, $26.38, and -$1.36 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | EyePoint | 398.53 Mn | 218.06 Mn | 507,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -3,231.36 |
| Jun 30, 2023 | -52.32 |
| Mar 31, 2023 | -26.54 |
| Dec 31, 2022 | -56.00 |
| Sep 30, 2022 | -27.79 |
| Jun 30, 2022 | -34.81 |
| Mar 31, 2022 | -15.31 |
| Dec 31, 2021 | -13.00 |
| Sep 30, 2021 | -11.03 |
| Jun 30, 2021 | -7.98 |
| Mar 31, 2021 | -8.12 |
| Dec 31, 2020 | -6.97 |
| Sep 30, 2020 | -1.06 |
| Jun 30, 2020 | -6.17 |
| Mar 31, 2020 | -6.41 |
| Dec 31, 2019 | -5.03 |
| Sep 30, 2019 | -7.94 |
| Jun 30, 2019 | -6.36 |
| Mar 31, 2019 | -14.36 |
| Dec 31, 2018 | -14.96 |